Key Enzyme Identified in Blood Transfusion Anti-Aging Effect
Scientists have pinpointed a specific enzyme that appears to underlie the cognitive rejuvenation observed in older mice following transfusions of young blood, a finding that sheds new light on the mechanisms behind the so-called "fountain of youth" effect. The research, published in the journal Cell Reports, identifies Tet2—an enzyme known to regulate gene activity—as a key player in the process, though its relevance to human aging remains an open question.
The experiments, conducted at the University of California, San Francisco (UCSF), used a technique called parabiosis, which joins the circulatory systems of two mice of different ages. In earlier work, scientists had shown that older mice receiving blood from younger mice or even from human teenagers showed improved learning and memory, but the underlying biological cause was unclear. The new study aimed to fill that gap by measuring levels of Tet2 in the brains of the connected mice.
The results were striking, according to lead author Geraldine Gontier, a researcher at UCSF. "At first I didn't believe it," she said, noting that she repeated the experiments multiple times to confirm the findings. "It became clear that some circulating factor in the blood is able to change the level of Tet2 in the brain," she added.
Why Tet2 Matters
Tet2, formally known as ten eleven translocation methylcytosine dioxygenase 2, is a known regulator of gene activity and has been previously associated with several age-related diseases. Mutations in Tet2 tend to accumulate with age and have been linked to conditions such as cancer, stroke, and cardiovascular disease. Researchers also suspect the enzyme plays a role in the regeneration of brain cells, which could explain its connection to cognitive function.
In the study, the team not only measured Tet2 levels but also manipulated its activity to demonstrate that changing the enzyme's levels had a significant impact on the cognitive abilities of the mice. This experimental approach provided direct evidence that Tet2 is not merely correlated with the anti-aging effect but is functionally involved.
Implications for Human Therapies
While the findings offer a clearer biological explanation for the earlier observations, translating them into human treatments remains a distant prospect. The researchers noted that Tet2 has yet to be identified in humans in the same context, and recent clinical trials involving young blood transfusions have not yet yielded definitive results. For those hoping to tap into the fountain of youth, the wait may be longer than expected.
The study adds to a growing body of research on the role of circulating factors in aging, but experts caution that much work remains before any therapeutic applications can be considered.
